Clinical Trial Detail

NCT ID NCT02048371
Title A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing/Ewing-like Sarcomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Sarcoma Alliance for Research through Collaboration
Indications

osteosarcoma

liposarcoma

Ewing sarcoma

Therapies

Regorafenib

Age Groups: adult

No variant requirements are available.